Clinical trial
Tailored Treatment in Metastatic Colorectal Cancer
NCT00396487 · Vejle Hospital, Other · Terminated
Key facts
| NCT number | NCT00396487 |
|---|---|
| Title | Tailored Treatment in Metastatic Colorectal Cancer |
| Official title | Tailored Treatment of Metastatic Colorectal Cancer Based on Genetic Markers |
| Lead sponsor | Vejle Hospital, Other |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Metastatic Colorectal Cancer |
| Intervention type | Drug |
| Interventions | Capecitabine, Irinotecan, 5-Fluorouracil+Calciumfolinat |
| Enrollment | 1 |
| Start date | Nov 1, 2006 |
| Completion | Feb 1, 2008 |
| First posted | Nov 7, 2006 |
| Last update posted | Jun 11, 2015 |
| Countries | Denmark |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: